Brain tumor classification from contrast-enhanced T1 MRI, a patient-wise deep learning study

Accurate classification of intracranial tumors on contrast-enhanced T1-weighted MRI (CE-T1) is challenged by heterogeneous enhancement patterns and strong correlations among multiple slices from the same patient. We propose a compact CE-T1 MRI analysis framework that standardizes image intensities, enhances local CLAHE (contrast using contrast-limited adaptive histogram equalization), and applies a lightweight convolutional classifier whose slice-level probabilities are aggregated to obtain a single patient-level prediction. An independent optional U-Net-based pathway provides binary tumor segmentation when spatial delineation is required. Evaluation was performed using a strictly patient-wise, leakage-controlled protocol with stratified five-fold cross-validation on 233 subjects (3,064 slices) comprising glioma, meningioma, and pituitary adenoma. The classifier achieved 99.4% patient-level accuracy, with macro-averaged sensitivity and specificity of 99.3% and 99.0%, respectively. The optional segmentation pathway achieved a mean Dice similarity coefficient of 97.3%. Post-hoc temperature scaling reduced the patient-level expected calibration error from 3.0% to approximately 1.2%, although larger independent cohorts are required to determine the stability of this estimate. The classifier contains 7.8 million parameters and requires approximately 15.9 GFLOPs per $$256\times 256$$ slice, with an end-to-end inference latency of approximately 0.41 s per slice under the evaluated hardware configuration. These findings demonstrate strong patient-level performance within the evaluated retrospective cohort. The framework is intended as a research-stage approach for reproducible evaluation rather than a clinically validated diagnostic system for routine radiology practice. However, no independent quantitative external validation was performed; therefore, multi-centre evaluation across different scanners, acquisition protocols, institutions, and patient populations is required before generalizability or clinical applicability can be established.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-79748-9
Primary Topic
Brain Tumor Detection and Classification
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Brain tumor classification from contrast-enhanced T1 MRI, a patient-wise deep learning study

Sultan Alamri, Muhammad Awais, Ahmed Ali, Rizwan Aziz Siddiqui et al.
Scientific Reports
Brain Tumor Detection and Classification
article

Brain tumor classification from contrast-enhanced T1 MRI, a patient-wise deep learning study

Sultan Alamri, Muhammad Awais, Ahmed Ali, Rizwan Aziz Siddiqui, Ahmad Joman Alghamdi, Abdullah A. Asiri, Mohammed Alshuhri, Magbool Alelyani, Khawlah Khalid Alateeq, Toufique Ahmed Soomro
article en

Abstract

Accurate classification of intracranial tumors on contrast-enhanced T1-weighted MRI (CE-T1) is challenged by heterogeneous enhancement patterns and strong correlations among multiple slices from the same patient. We propose a compact CE-T1 MRI analysis framework that standardizes image intensities, enhances local CLAHE (contrast using contrast-limited adaptive histogram equalization), and applies a lightweight convolutional classifier whose slice-level probabilities are aggregated to obtain a single patient-level prediction. An independent optional U-Net-based pathway provides binary tumor segmentation when spatial delineation is required. Evaluation was performed using a strictly patient-wise, leakage-controlled protocol with stratified five-fold cross-validation on 233 subjects (3,064 slices) comprising glioma, meningioma, and pituitary adenoma. The classifier achieved 99.4% patient-level accuracy, with macro-averaged sensitivity and specificity of 99.3% and 99.0%, respectively. The optional segmentation pathway achieved a mean Dice similarity coefficient of 97.3%. Post-hoc temperature scaling reduced the patient-level expected calibration error from 3.0% to approximately 1.2%, although larger independent cohorts are required to determine the stability of this estimate. The classifier contains 7.8 million parameters and requires approximately 15.9 GFLOPs per $$256\times 256$$ slice, with an end-to-end inference latency of approximately 0.41 s per slice under the evaluated hardware configuration. These findings demonstrate strong patient-level performance within the evaluated retrospective cohort. The framework is intended as a research-stage approach for reproducible evaluation rather than a clinically validated diagnostic system for routine radiology practice. However, no independent quantitative external validation was performed; therefore, multi-centre evaluation across different scanners, acquisition protocols, institutions, and patient populations is required before generalizability or clinical applicability can be established.

Scientific Reports
University of East Anglia (GB), Prince Sattam Bin Abdulaziz University (SA), Charles Sturt University (AU), Taif University (SA), King Saud University (SA), Najran University (SA), Quaid-e-Awam University of Engineering, Science and Technology (PK), King Khalid University (SA)
Najran University
Good health and well-being
Brain Tumor Detection and Classification
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon